Pernix Therapeutics Holdings, Inc. — Revenue by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/32283f3f-b327-44ad-a571-8accaecead1c/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2017 | $146.1M | 2017-01-01 – 2017-12-31 | evidence 0001136261-18-000075 |
| FY 2016 | $140.9M | 2016-01-01 – 2016-12-31 | evidence 0001136261-17-000069 |
| FY 2015 | $175.8M | 2015-01-01 – 2015-12-31 | evidence 0001136261-16-000419 |
| FY 2014 | $121.7M | 2014-01-01 – 2014-12-31 | evidence 0001136261-16-000419 |
| FY 2013 | $84.9M | 2013-01-01 – 2013-12-31 | evidence 0001136261-16-000419 |
| FY 2012 | $61.3M | 2012-01-01 – 2012-12-31 | evidence 0001354488-15-000878 |
| FY 2011 | $60.6M | 2011-01-01 – 2011-12-31 | evidence 0001354488-14-001218 |
| FY 2010 | $33.2M | 2010-01-01 – 2010-12-31 | evidence 0001354488-12-001488 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Pernix Therapeutics Holdings, Inc. — all facts · Net Income · Operating Income